1. Home
  2. PROF vs AFCG Comparison

PROF vs AFCG Comparison

Compare PROF & AFCG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PROF
  • AFCG
  • Stock Information
  • Founded
  • PROF N/A
  • AFCG 2020
  • Country
  • PROF Canada
  • AFCG United States
  • Employees
  • PROF N/A
  • AFCG N/A
  • Industry
  • PROF Medical/Dental Instruments
  • AFCG Real Estate Investment Trusts
  • Sector
  • PROF Health Care
  • AFCG Real Estate
  • Exchange
  • PROF Nasdaq
  • AFCG Nasdaq
  • Market Cap
  • PROF 201.2M
  • AFCG 189.9M
  • IPO Year
  • PROF N/A
  • AFCG 2021
  • Fundamental
  • Price
  • PROF $7.48
  • AFCG $7.91
  • Analyst Decision
  • PROF Strong Buy
  • AFCG Buy
  • Analyst Count
  • PROF 2
  • AFCG 6
  • Target Price
  • PROF $11.40
  • AFCG $12.00
  • AVG Volume (30 Days)
  • PROF 102.1K
  • AFCG 170.0K
  • Earning Date
  • PROF 03-06-2025
  • AFCG 03-13-2025
  • Dividend Yield
  • PROF N/A
  • AFCG 19.86%
  • EPS Growth
  • PROF N/A
  • AFCG N/A
  • EPS
  • PROF N/A
  • AFCG 0.40
  • Revenue
  • PROF $8,984,000.00
  • AFCG $43,164,939.00
  • Revenue This Year
  • PROF $56.56
  • AFCG N/A
  • Revenue Next Year
  • PROF $151.33
  • AFCG N/A
  • P/E Ratio
  • PROF N/A
  • AFCG $30.83
  • Revenue Growth
  • PROF 39.35
  • AFCG N/A
  • 52 Week Low
  • PROF $5.63
  • AFCG $7.45
  • 52 Week High
  • PROF $11.42
  • AFCG $10.88
  • Technical
  • Relative Strength Index (RSI)
  • PROF 65.75
  • AFCG 31.84
  • Support Level
  • PROF $5.63
  • AFCG $8.06
  • Resistance Level
  • PROF $6.36
  • AFCG $8.88
  • Average True Range (ATR)
  • PROF 0.36
  • AFCG 0.22
  • MACD
  • PROF 0.18
  • AFCG -0.00
  • Stochastic Oscillator
  • PROF 87.26
  • AFCG 10.19

About PROF Profound Medical Corp.

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.

About AFCG AFC Gamma Inc.

Advanced Flower Capital Inc is a commercial mortgage REIT that provides institutional loans to state-law-compliant cannabis operators in the U.S. Through the management team's deep network and significant credit and cannabis expertise, AFC originates, structures and underwrites loans ranging from $10 million to over $100 million, typically secured by quality real estate assets, license value and cash flows.

Share on Social Networks: